Angene Chemical
Draw
|
Currency :
Home Products

AG003HZB

104-98-3 | Urocanic acid

Chemical structure of Urocanic acid, CAS 104-98-3
AG003HZB
sdsSDS
sdsCOA

Price

$0.00

Add to Cart
WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 104-98-3
Catalog Number AG003HZB(AGN-PC-0NVYHT)
Chemical Name Urocanic acid
EC Number 203-258-4
IUPAC Name (E)-3-(1H-imidazol-5-yl)prop-2-enoic acid
InChI InChI=1S/C6H6N2O2/c9-6(10)2-1-5-3-7-4-8-5/h1-4H,(H,7,8)(H,9,10)/b2-1+
InChI Key LOIYMIARKYCTBW-OWOJBTEDSA-N
MDL Number MFCD00149316
Molecular Formula C6H6N2O2
Molecular Weight 138.1240
SMILES OC(=O)C=CC1=CNC=N1
UNII G8D26XJJ3B
Synonyms
Acid, Glyoxalinylacrylic, Acid, Urocanic, Glyoxalinylacrylic Acid, Urocanic Acid, urocanic acid, 4-imidazoleacrylic acid, trans-Urocanic acid, 104-98-3, Urocaninic acid, imidazoleacrylic acid, 3465-72-3, 5-Imidazoleacrylic acid, urocanate, Imidazole-4-acrylic acid, (2E)-3-(1H-IMIDAZOL-4-YL)ACRYLIC ACID, 3-Imidazol-4-ylacrylic acid, 3-(1H-Imidazol-4-yl)-2-propenoic acid, (2E)-3-(1H-imidazol-4-yl)prop-2-enoic acid, UNII-G8D26XJJ3B, (E)-3-(1H-Imidazol-4-yl)-2-propenoic acid, 2-Propenoic acid, 3-(1H-imidazol-4-yl)-, NSC 66357, UROCANIC ACID, CIS, G8D26XJJ3B, (e)-3-(1h-imidazol-4-yl)acrylic acid, 3-(4-Imidazolyl)acrylic acid, MLS000069482, CHEBI:30817, LOIYMIARKYCTBW-OWOJBTEDSA-N, 2-Propenoic acid, 3-(1H-imidazol-4-yl)-, (2E)-, (E)-3-(1H-imidazol-5-yl)acrylic acid, 3-(1H-imidazol-4-yl)prop-2-enoic acid, SMR000059098, Imidazole-4-propene-2-enoic acid [Urocanic acid], 4-IMIDAZOLE ACRYLIC ACID DIHYDRATE, CCRIS 3414, EINECS 203-258-4, (E)-Urocanic acid, BRN 0081405, (2E)-3-imidazol-4-ylprop-2-enoic acid, (E)-3-(imidazol-4-yl)propenoate, 5-Imidazoleacrylate, zlchem 24, MFCD00005203, Imidazole-4-acrylate, imidazolylpropenoicacid, PubChem9875, (E)-3-(1H-Imidazol-5-yl)-2-propenoic acid, (Z)-3-(3H-imidazol-4-yl)prop-2-enoic Acid, AC1LEIQR, Opera_ID_26, 3-(4-Imidazolyl)acrylate, bmse000279, AC1Q5T9G, AC1Q71IX, DSSTox_CID_21148, DSSTox_RID_79635, DSSTox_GSID_41148, Lopac0_001255, SCHEMBL15417, trans-4-imidazoleacrylic acid, MLS001148240, 2-Propenoic acid, 3-(1H-imidazol-4-yl)-, (E)-, 4-Imidazoleacrylic acid, 99%, AC1Q71Y1, Jsp000483, 3-(1H-Imidazol-4-yl)acrylate, CHEMBL1236602, DTXSID5041148, CHEBI:27248, ZLB0011, E-3-(4-imidazolyl)propenoic acid, HMS2234N08, HMS3263L12, ACT02032, ALBB-025618, NSC66357, (E)-3-(4-Imidazolyl)acrylic acid, Tox21_202978, Tox21_501255, BBL027507, MFCD01593677, NSC-66357, NSC407934, SBB006702, STK735136, ZINC34633903, (E)-3-(imidazol-4-yl)acrylic acid, 3-(3H-Imidazol-4-yl)-acrylic acid, 3-(1H-Imidazol-4-yl)-2-propenoate, AKOS001745677, AKOS005265082, AKOS022488522, (e)-3-(Imidazol-4-yl)propenoic acid, CCG-205329, DB01971, HS-0075, LP01255, NSC-407934, RP09780, RTR-032578, NCGC00094495-01, NCGC00094495-02, NCGC00094495-03, NCGC00260524-01, NCGC00261940-01, CAS-104-98-3, CJ-18538, LS-78025, SC-00208, ST085933, 3-(1H-Imidazol-5-yl)-2-Propenoic acid, 3-Azonia-1H-imidazole-5-acrylic acidanion, HY-113008, TR-032578, CS-0059340, EU-0101255, I0002, R1116, (E)-3-(1H-imidazol-4-yl)prop-2-enoic acid, (E)-3-(1H-imidazol-5-yl)prop-2-enoic acid, 3-(1H-Imidazol-4-yl)-(E)-2-Propenoic acid, C00785, U 7500, (2E)-3-(1H-imidazol-5-yl)prop-2-enoic acid, (2E)-3-(3H-imidazol-4-yl)prop-2-enoic acid, SR-01000076189, I04-0134, SR-01000076189-1, W-108797, 23A7DA77-EC02-46B9-AA22-514C2B2A62E9, 3-(1h-imidazol-4-yl)-2-propenoicaci ;3-(1h-imidazol-4-yl)-2-propenoicacid, cis-Urocanic acid, trans-urocanate, ProtoCure, Acid, Urocanic, -3- propenoicacid, Glyoxalinylacrylic Acid, Acid, Glyoxalinylacrylic, 3-imidazol-4-ylacrylsyre, D04CQV, 3-(1H-imidazol-4-yl)acrylic acid, (Z)-Imidazole-4-acrylic acid, C6H6N2O2, 3- imidazol- 4- ylacrylic acid, C6-H6-N2-O2, AR-1E5184, CID736715, (2E)-3-(1H-Imidazole-4-yl)propenoic acid, 2-Propenoic acid, 3-(1H-imidazol-5-yl)-, A13624, 4-25-00-00786 (Beilstein Handbook Reference), D014560, ProtoCure (emulsion, atopic dermatitis), Biocis Pharma, ProtoCure (emulsion, atopic dermatitis/psoriasis), Laurantis, Anti-inflammatory (topical emulsion, dermatological disease), BioCis, Cis-UCA (topical emulsion, atopic dermatitis/psoriasis), Laurantis, ProtoCure (emulsion, atopic dermatitis/psoriasis), Biocis Pharma, 7699-35-6, Cis-UCA (topical emulsion, atopic dermatitis/psoriasis), BioCis Pharma, URO, Cis-urocanic acid (topical emulsion, atopic dermatitis/psoriasis), BioCis Pharma, 10557-55-8,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited